Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$302M Buy
2,941,100
+2,454,000
+504% +$277M 0.05% 422
2025
Q4
$61M Sell
487,100
-73,600
-13% -$9.38M 0.01% 1418
2025
Q3
$75.1M Buy
560,700
+131,000
+30% +$17.2M 0.01% 1266
2025
Q2
$58.4M Sell
429,700
-60,400
-12% -$7.96M 0.01% 1372
2025
Q1
$65M Sell
490,100
-222,900
-31% -$28.4M 0.01% 1239
2024
Q4
$80.6M Sell
713,000
-300
-0% -$34.7K 0.01% 1055
2024
Q3
$81.3M Buy
713,300
+218,100
+44% +$23.9M 0.02% 847
2024
Q2
$51.5M Sell
495,200
-133,100
-21% -$14.1M 0.01% 1024
2024
Q1
$71.4M Sell
628,300
-147,748
-19% -$16.9M 0.02% 827
2023
Q4
$85.4M Buy
776,048
+464,448
+149% +$46.4M 0.03% 659
2023
Q3
$30.2M Buy
311,600
+13,000
+4% +$1.37M 0.01% 1175
2023
Q2
$32.6M Buy
298,600
+98,300
+49% +$10.5M 0.01% 1093
2023
Q1
$20.3M Buy
200,300
+7,100
+4% +$750K 0.01% 1381
2022
Q4
$21.2M Sell
193,200
-46,100
-19% -$4.77M 0.01% 1365
2022
Q3
$23.2M Buy
239,300
+170,000
+245% +$18.1M 0.01% 1174
2022
Q2
$7.53M Buy
69,300
+17,500
+34% +$1.99M ﹤0.01% 2037
2022
Q1
$6.13M Sell
51,800
-383,300
-88% -$47.5M ﹤0.01% 2346
2021
Q4
$61.2M Sell
435,100
-159,967
-27% -$20.5M 0.02% 844
2021
Q3
$70.3M Buy
595,067
+115,000
+24% +$14.1M 0.02% 691
2021
Q2
$55.7M Sell
480,067
-55,800
-10% -$6.5M 0.02% 793
2021
Q1
$64.2M Buy
535,867
+232,967
+77% +$27.6M 0.02% 695
2020
Q4
$33.2M Buy
302,900
+78,900
+35% +$8.58M 0.01% 1024
2020
Q3
$24.4M Buy
224,000
+3,900
+2% +$396K 0.01% 1043
2020
Q2
$20.1M Buy
220,100
+173,100
+368% +$15.6M 0.01% 1081
2020
Q1
$3.71M Sell
47,000
-114,000
-71% -$9.51M ﹤0.01% 2185
2019
Q4
$14M Buy
161,000
+107,800
+203% +$9.03M ﹤0.01% 1649
2019
Q3
$4.45M Buy
53,200
+2,700
+5% +$229K ﹤0.01% 2498
2019
Q2
$4.25M Sell
50,500
-500
-1% -$39.4K ﹤0.01% 2463
2019
Q1
$4.08M Sell
51,000
-5,000
-9% -$372K ﹤0.01% 2373
2018
Q4
$4.05M Buy
56,000
+1,000
+2% +$70.3K ﹤0.01% 2346
2018
Q3
$4.04M Buy
55,000
+13,400
+32% +$880K ﹤0.01% 2552
2018
Q2
$2.54M Sell
41,600
-5,500
-12% -$333K ﹤0.01% 2949
2018
Q1
$2.82M Buy
+47,100
New +$2.84M ﹤0.01% 2827
2017
Q4
Sell
-2,500
Closed -$133K 7809
2017
Q3
$133K Buy
2,500
+1,500
+150% +$75.3K ﹤0.01% 5139
2017
Q2
$49K Sell
1,000
-10,000
-91% -$453K ﹤0.01% 5650
2017
Q1
$488K Sell
11,000
-474,400
-98% -$20.5M ﹤0.01% 4058
2016
Q4
$18.6M Buy
485,400
+174,700
+56% +$6.93M 0.01% 1071
2016
Q3
$13.1M Sell
310,700
-101,400
-25% -$4.34M 0.01% 1226
2016
Q2
$16.2M Buy
412,100
+164,600
+67% +$6.55M 0.01% 1071
2016
Q1
$10.4M Buy
247,500
+233,400
+1,655% +$9.25M 0.01% 1304
2015
Q4
$633K Sell
14,100
-3,600
-20% -$159K ﹤0.01% 3764
2015
Q3
$712K Buy
17,700
+3,300
+23% +$156K ﹤0.01% 3629
2015
Q2
$706K Sell
14,400
-4,400
-23% -$211K ﹤0.01% 3841
2015
Q1
$871K Sell
18,800
-12,500
-40% -$574K ﹤0.01% 3690
2014
Q4
$1.41M Buy
+31,300
New +$1.36M ﹤0.01% 3263

Other funds holding ABT

UBS Group's ABT Position: Q1 2026 in Review

UBS Group increased its Abbott (ABT) stake by 16% in Q1 2026, buying an estimated $189M and bringing the position to 12,152,765 shares worth $1.25B. The position accounts for 0.19% of the portfolio, ranked #99.

UBS Group first reported a position in ABT in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.31B in Q3 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • UBS Group held 12,152,765 shares of Abbott worth $1.25B as of Q1 2026.
  • UBS Group bought 1,672,696 Abbott shares in Q1 2026, an estimated $189M.
  • Abbott made up 0.19% of UBS Group's portfolio in Q1 2026, its #99 holding.
  • UBS Group first reported a position in Abbott in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Abbott position peaked at $1.31B in Q3 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.